Four
member companies of BIoLabs LA are part of the 4-month pilot program designed to identify and accelerate the best possible outcome for each company in its sector.
The 4 early-stage bioscience companies participating in the 2021 pilot cohort are:
• Hawkeye Bio (www.hawkeyebio.com): Non-invasive cancer detected from breath, blood, or
saliva for early detection of lung, breast, prostate, and pancreatic cancers,
• SNJ Pharma (www.snjpharma.com): Novel therapeutic, non-toxic, nanoparticles for targeted
delivery and pharmabiotics,
• Tender Light Scientific (www.tender-light.com): Portable devices using diffuse reflectance
spectroscopy (DRS) systems for neonatal care to monitor health status, and,
• Triton Bio (www.tritonbio.com): Diagnostic instruments to rapidly determine the antibiotic
resistance of bacteria and fungi causing life-threatening infections.
More Information about Heal.LA Biosciences Accelerator
Heal.LA will offer companies and partners a variety of valuable tools and services as part of this
innovative program, including:
• Up to $50,000 in business and commercialization services at no cost to the startups
• Access to Larta’s vast virtual platform of webinars and other tech-to-market tools such as
research reports, templates, and other materials tailored to specific areas of growth
• Direct 1-on-1 guidance between vetted entrepreneurs and world-class industry experts in
Medical Devices, Biotechnology, Digital Health, Diagnostics, Pharmaceuticals, and more
• Expert feedback and validation of strategies for market and product fit for both early and
later-stage companies
• Access to industry partners for potential collaboration and fundraising
• Demo Day events featuring industry and investors providing market and investment leads
and opportunities through curated private introductions
Comments